1. /
  2. About us /
  3. Our people and structure /
  4. Our people /
  5. Rebecca Winter
Our people

Dr Rebecca Winter

Deputy Head, Justice Health

Taking students

Working groups

rebecca.winter@burnet.edu.au
Dr Rebecca Winter

Background

Rebecca Winter has over 15 years of experience in public health research. Primarily, she has worked on studies relating to risk behaviours and risk groups relating to communicable disease transmission, with a particular interest in drug user and justice-involved populations.

Rebecca completed her doctoral studies on injecting drug-related harms among prisoners and ex-prisoners in 2016.

Qualifications

  • 2017: PhD, Monash University, Australia
  • 2010: MPH, Latrobe University, Australia
  • 2002: BA, Latrobe University, Australia

Appointments

  • Burnet Fellow; Honorary Research Fellow, St Vincent's Hospital Melbourne
  • Adjunct Research Fellow, School of Public Health and Preventive Medicine, Monash University

Awards

  • 2016: Burnet Institute Travel Award
  • 2013: ICAAP (International Conference on AIDS in Asia and the Pacific) student scholarship, Bangkok, Thailand
  • 2012: NIDA Conference Scholarship, Academic and Health Policy Conference on Correctional Health, Atlanta, GA, USA
  • 2010: National Health and Medical Research Council (NHMRC) PhD Scholarship, Dora Lush Public Health Scholarship

Positions

  • 2022: Deputy Head Justice Health Group
  • 2022: Research Fellow, Burnet Institute
  • 2020: Senior Research Officer, Burnet Institute
  • 2016: Research Officer, Burnet Institute
  • 2011-2016: PhD candidate, Monash University and Burnet Institute
  • 2005-2010: Research Assistant, Burnet Institute

Reports and other work

  • Technical review of hepatitis C health promotion resources.

    The hepatitis C virus impacts approximately 200,000 Australians, according to the National Centre in HIV Epidemiology and Clinical Research (NCHECR) in 2010. Presently, there is no vaccine available to prevent transmission of the virus. In New South Wales alone, there were 3,950 new diagnoses of hepatitis C infection in 2009, as reported by the NCHECR.

    Technical review of hepatitis C health promotion resources.

Burnet publications

View 53 more
27 Mar 2025

"Quick, simple, and friendly": Understanding the acceptability and accessibility of a nurse and peer-led, mobile model of hepatitis C care adjacent to community corrections in Australia

International Journal of Drug Policy

S. Griffin, Shelley Walker, Sophia Schroeder, Margaret Hellard, Mark Stoové, Rebecca Winter

Open access
24 Mar 2025

The costs and benefits of a prison needle and syringe program in Australia, 2025–30: a modelling study

The Medical Journal of Australia

Rebecca Winter, Farah Houdroge, Samantha Colledge‐Frisby, Mark Stoové, Nick Scott, Farah Houdroge, Samantha Colledge‐Frisby, Rebecca Winter, Mark Stoové, Nick Scott

Open access
24 Mar 2025

The costs and benefits of a prison needle and syringe program in Australia, 2025–30: a modelling study

The Medical Journal of Australia

Rebecca Winter, Farah Houdroge, Samantha Colledge‐Frisby, Mark Stoové, Nick Scott, Farah Houdroge, Samantha Colledge‐Frisby, Rebecca Winter, Mark Stoové, Nick Scott

Open access

Current projects

Achieving the final phases of hepatitis C elimination using innovative models of care

Achieving the final phases of hepatitis C elimination using innovative models of care

We're identifying innovative models of care so that no-one misses out on HCV care in Australia and globally.

The C No More Project: Community corrections Nurse-led Model of care to Eliminate hepatitis C
Open to students

The C No More Project: Community corrections Nurse-led Model of care to Eliminate hepatitis C

This study will offer free hepatitis C testing and treatment to people in community corrections and assess the effectiveness of the model of care. 

Past projects

View 3 more
The elimination of hepatitis C as a global public health threat

The elimination of hepatitis C as a global public health threat

This project addresses critical knowledge gaps in Australian and global efforts to eliminate hepatitis C as a public health threat by 2030.

Eliminate C (EC) Victoria partnership

Eliminate C (EC) Victoria partnership

A partnership aimed at increasing hepatitis C treatment uptake among people who inject drugs (PWID) using nurse-led models of care in community and prison settings.

Feasibility study for a potential medically supervised injecting centre/drug consumption service for the ACT

Feasibility study for a potential medically supervised injecting centre/drug consumption service for the ACT

This study provided evidence on whether a supervised drug consumption room (or rooms) is suited to the ACT context.

View 3 more

News and features

NHMRC funding boost for hepatitis C elimination

NHMRC funding boost for hepatitis C elimination

Burnet will use the AUD$5 million to identify new ways of engaging the estimated 70,000 Australians living with Hepatitis C virus to receive care.

On this page